Concepedia

Enduo Qiu

EQ

15

Publications

393

Citations

13

H-Index

2016

Active since

Affiliations

China Medical University(Current)

Liaoning Cancer Hospital & Institute

Enduo Qiu is an author at China Medical University specializing in cancer research, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2016–2021

15

Publications

15

CircDOCK1 promotes the tumorigenesis and cisplatin resistance of osteogenic sarcoma via the miR-339-3p/IGF1R axis

Shenglong Li, Fei Liu, Ke Zheng et al. · Molecular Cancer · 2021 · 102 citations · Full text

Long non-coding RNA AFAP1-AS1 accelerates the progression of melanoma by targeting miR-653-5p/RAI14 axis

Fei Liu, Lanting Hu, Yi Pei et al. · BMC Cancer · 2020 · 48 citations · Full text

Protection of oxidative stress induced apoptosis in osteosarcoma cells by dihydromyricetin through down-regulation of caspase activation and up-regulation of BcL-2

Yuming Wang, Wei Wang, Enduo Qiu · Saudi Journal of Biological Sciences · 2016 · 38 citations · Full text

Magnoflorine inhibits the malignant phenotypes and increases cisplatin sensitivity of osteosarcoma cells via regulating miR-410-3p/HMGB1/NF-κB pathway

Yuming Wang, Guanning Shang, Wei Wang et al. · Life Sciences · 2020 · 34 citations

, , +10

Osteosarcoma cells induce differentiation of mesenchymal stem cells into cancer associated fibroblasts through Notch and Akt signaling pathway.

Yuming Wang, Wei Wang, Enduo Qiu · PubMed · 2017 · 26 citations · Full text

, , +16

Rows per page

1–5 of 15